How To Invest In ARS Pharmaceuticals, Inc. Stock - SPRY Share Price Today & News | Stash

Invest in ARS Pharmaceuticals, Inc. on Stash

ARS Pharmaceuticals, Inc., formerly Silverback Therapeutics, Inc., is a biopharmaceutical company.

To buy fractional shares of ARS Pharmaceuticals, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.

Ticker: SPRY

ARS Pharmaceuticals, Inc.

$7.00

-11.17%
(1W)

SPRY Performance Breakdown

• Share Price: $7.00
• Today's change: -6.17%
• Year to date change (YTD): -39.08%
• Dividend yield: 0.0
• Last dividend paid: N/A
• Last dividend pay date: N/A

About SPRY

ARS Pharmaceuticals, Inc., formerly Silverback Therapeutics, Inc., is a biopharmaceutical company. The Company is developing neffy (previously referred to ARS-1), an intranasal epinephrine product in clinical development for patients and their caregivers with Type 1 allergic reactions, including food, medications, and insect bites that could lead to anaphylaxis. The Company has designed and developed neffy to provide injection-like absorption of epinephrine, in a small nasal spray device.

How to buy ARS Pharmaceuticals, Inc. stock on Stash

1. Enter the amount you'd like to invest in ARS Pharmaceuticals, Inc. stock, then proceed to checkout. Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
2. Set up your investment account in just a few minutes. Stash offers one subscription plan: The Stash Plan.
3. Once you’ve finished your account, your ARS Pharmaceuticals, Inc. shares will be added to your new portfolio.

Disclaimer

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.